BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3539299)

  • 21. Thionamide-induced Agranulocytosis: A Retrospective Analysis of 36 Patients With Hyperthyroidism.
    Zhu D; Zhang S; Cao X; Xia Q; Zhang Q; Deng D; Gao S; Yu H; Liu Y; Zhou H; Tao F; Sun X
    Endocr Pract; 2021 Dec; 27(12):1183-1188. PubMed ID: 34216800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
    Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH
    Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody].
    Ye H; Gao Y; Guo XH; Zhao MH
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3323-7. PubMed ID: 16409836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent agranulocytosis induced by two different antithyroid agents.
    Chen B; Lang R; Jutrin Y; Ravid M
    Med J Aust; 1983 Jul; 2(1):38-9. PubMed ID: 6865827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antithyroid drug-induced agranulocytosis. A rare but dreaded condition].
    Lehtihet M; Zedenius J; Helldén A; Axelsson R; Calissendorff J
    Lakartidningen; 2009 Oct 7-13; 106(41):2607-8, 2610-1. PubMed ID: 19927925
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic adverse effect of antithyroid drugs.
    Mathieu E; Fain O; Sitbon M; Thomas M
    Clin Rheumatol; 1999; 18(1):66-8. PubMed ID: 10088956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose.
    Cooper DS; Goldminz D; Levin AA; Ladenson PW; Daniels GH; Molitch ME; Ridgway EC
    Ann Intern Med; 1983 Jan; 98(1):26-9. PubMed ID: 6687345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Major adverse reactions to propylthiouracil in 586 cases of hyperthyroidism].
    Frenkel J; Téllez R; Reyes C; González G; Michaud P
    Rev Med Chil; 1993 Nov; 121(11):1289-94. PubMed ID: 8191137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rare side effects in management of hyperthyroidism. Case report].
    Sohár G; Kovács M; Györkös A; Gasztonyi B
    Orv Hetil; 2016 May; 157(22):869-72. PubMed ID: 27211356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of hypo- and hyperthyroidism in pregnancy].
    Lind P
    Acta Med Austriaca; 1997; 24(4):157-8. PubMed ID: 9441554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous vasculitis associated with propylthiouracil therapy.
    Carrasco MD; Riera C; Clotet B; Grifol M; Foz M
    Arch Intern Med; 1987 Sep; 147(9):1677. PubMed ID: 3632175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithyroid drugs.
    Cooper DS
    N Engl J Med; 1984 Nov; 311(21):1353-62. PubMed ID: 6387489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature.
    Kitahara T; Hiromura K; Maezawa A; Ono K; Narabara N; Yano S; Naruse T; Takenouchi K; Yasumoto Y
    Clin Nephrol; 1997 May; 47(5):336-40. PubMed ID: 9181282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The adverse effects of thioureylene antithyroid drugs (author's transl)].
    Nakashima T; Okamura K; Yoshinari M; Shiroozu A; Nishitani H; Okabe N; Inoue K; Omae T
    Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):225-33. PubMed ID: 6212270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy.
    Amrhein JA; Kenny FM; Ross D
    J Pediatr; 1970 Jan; 76(1):54-63. PubMed ID: 5410161
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatotoxicity from antithyroid drugs.
    Vitug AC; Goldman JM
    Horm Res; 1985; 21(4):229-34. PubMed ID: 4007783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Presentation of a case of Graves' disease with neutropenia and splenomegaly: propylthiouracil-induced autoimmune neutropenia and review of the literature on the drug-induced lupus-like syndrome].
    Miyakawa M; Sato K; Sato Y; Tsushima T; Shizume K; Inoue T
    Nihon Naika Gakkai Zasshi; 1984 Apr; 73(4):538-45. PubMed ID: 6547974
    [No Abstract]   [Full Text] [Related]  

  • 40. Unusual complications of antithyroid drug therapy: four case reports and review of literature.
    Baker B; Shapiro B; Fig LM; Woodbury D; Sisson JC; Beierwaltes WH
    Thyroidology; 1989 Apr; 1(1):17-26. PubMed ID: 2484903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.